BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7870135)

  • 1. Inhibition of Trypanosoma cruzi trypanothione reductase by crystal violet.
    Moreno SN; Carnieri EG; Docampo R
    Mol Biochem Parasitol; 1994 Oct; 67(2):313-20. PubMed ID: 7870135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds.
    Jockers-Scherübl MC; Schirmer RH; Krauth-Siegel RL
    Eur J Biochem; 1989 Mar; 180(2):267-72. PubMed ID: 2647489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype of recombinant Leishmania donovani and Trypanosoma cruzi which over-express trypanothione reductase. Sensitivity towards agents that are thought to induce oxidative stress.
    Kelly JM; Taylor MC; Smith K; Hunter KJ; Fairlamb AH
    Eur J Biochem; 1993 Nov; 218(1):29-37. PubMed ID: 8243474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis and inhibitory activity of dethiotrypanothione and analogues against trypanothione reductase.
    Czechowicz JA; Wilhelm AK; Spalding MD; Larson AM; Engel LK; Alberg DG
    J Org Chem; 2007 May; 72(10):3689-93. PubMed ID: 17439174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
    Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
    Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting effects of spermidine derivatives on Trypanosoma cruzi trypanothione reductase.
    O'Sullivan MC; Dalrymple DM; Zhou Q
    J Enzyme Inhib; 1996 Oct; 11(2):97-114. PubMed ID: 9204399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
    Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
    Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme.
    Krauth-Siegel RL; Enders B; Henderson GB; Fairlamb AH; Schirmer RH
    Eur J Biochem; 1987 Apr; 164(1):123-8. PubMed ID: 3549299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone, a non-competitive inhibitor of trypanothione reductase.
    Zani CL; Fairlamb AH
    Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):565-8. PubMed ID: 12937775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanothione-dependent peroxide metabolism in Trypanosoma cruzi different stages.
    Carnieri EG; Moreno SN; Docampo R
    Mol Biochem Parasitol; 1993 Sep; 61(1):79-86. PubMed ID: 8259135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals.
    Cunningham ML; Zvelebil MJ; Fairlamb AH
    Eur J Biochem; 1994 Apr; 221(1):285-95. PubMed ID: 8168518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
    Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
    Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
    J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
    Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase.
    Bonnet B; Soullez D; Davioud-Charvet E; Landry V; Horvath D; Sergheraert C
    Bioorg Med Chem; 1997 Jul; 5(7):1249-56. PubMed ID: 9377084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.
    Benson TJ; McKie JH; Garforth J; Borges A; Fairlamb AH; Douglas KT
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):9-11. PubMed ID: 1355650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
    González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
    Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamines with N-(3-phenylpropyl) substituents are effective competitive inhibitors of trypanothione reductase and trypanocidal agents.
    Li Z; Fennie MW; Ganem B; Hancock MT; Kobaslija M; Rattendi D; Bacchi CJ; O'Sullivan MC
    Bioorg Med Chem Lett; 2001 Jan; 11(2):251-4. PubMed ID: 11206471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.